This site is intended for Healthcare Professionals only.

New Law: Full packs of Valproate-containing medicines now come with safety warning

Date:

Share post:

Patients will receive warnings and pictograms, including a patient card and the Patient Information Leaflet with the pack

The Department of Health and Social Care (DHSC) and the Medicines and Healthcare Products Regulatory Agency (MHRA) have authorised community pharmacies throughout the UK to dispense original full packs of Valproate-containing medicines upon prescription.

The necessary changes in regulations came into effect on 11 October which was strongly supported by 85 per cent of respondents concerned about risks to the unborn baby if valproate-containing medicines are used in pregnancy.

The decision was made to ensure patients receive safety warnings and pictograms, including a patient card and the Patient Information Leaflet (PIL), contained in the manufacturer’s original full pack.

Valproate is a treatment for epilepsy and bipolar disorder but is also associated with birth defects and neurological disabilities.

Dr June Raine, MHRA Chief Executive spoke about the necessary changes in the law and said, “It is essential that all patients on valproate-containing medicines receive the latest safety information every time their prescription is dispensed.

“The changes in the law announced today to ensure this happens,” he added.

“People’s situation may change, especially with regard to the possibility of pregnancy, so it is vital that the warnings about the harms of valproate are always brought to mind.”

He continued: “It is very important that patients do not stop taking valproate-containing medicines without advice from a healthcare professional. If you are concerned about the risks, talk to your doctor, pharmacist or another healthcare professional.”

However, pharmacists can make an exception to dispense valproate-containing medicines in the manufacturer’s original full pack on an individual patient basis.

It will be only considered if the patient needs a monitored dosage system, and must receive the Patient Information Leaflet which contains information about the risks of valproate-containing medicine for the unborn child.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Alarming Stats: 1 in 2 British children feel low confidence due to their teeth’s appearance

Missing, discoloured, and crooked teeth top reasons for children's smile insecurities A new study by oral health brand...

NHS App messaging delivers 1.1 million in savings for NHS

69% surge in monthly logins reflects vital role of NHS App in modern healthcare delivery In a remarkable turn...

 PDA partners with Aston University to expand pharmacists’ role in clinical services

Research outcomes set to bolster PDA's NHS advocacy, paving the way for enhanced pharmacist involvement in patient care In...

18% flexible health and social care workers considering leaving the sector, new report reveals

Challenges facing the UK’s health and care sector exposed. Many flexible workers reported feeling overstretched by their workload Highlighting...